ATTR Amyloidosis Treatment Market is driven by rising market demand

Ajouter une nouvelle offre d'emploi Health

2025-06-04 10:38:25 -

The ATTR Amyloidosis Treatment Market encompasses therapies designed to address transthyretin (ATTR) amyloidosis, a progressive disorder characterized by abnormal protein deposits in organs and tissues. Core products include RNA interference (RNAi) therapies, monoclonal antibodies, and small-molecule stabilizers that prevent transthyretin misfolding. Advantages of these treatments lie in...

0 Commentaires 0 Parts 181 Vue 0 Aperçu